Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.… Read more The PCSK9-REACT study

Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.… Read more The PCSK9-REACT study
Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome: A Narrative Review. Navarese EP, Kolodziejczak M, Kereiakes DJ,… Read more PCSK9 antibodies for ACS: A Narrative Review
Role of PCSK9 antibodies in cardiovascular disease: Critical considerations of mortality and neurocognitive findings from the current literature. Kołodziejczak M,… Read more PCSK9 antibodies: Critical considerations of mortality and neurocognitive findings
From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications Navarese EP, Kołodziejczak M, Dimitroulis D, Wolff… Read more From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications
Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes. Comprehensive network meta-analysis of 42 randomised trials involving 117,353… Read more Anticoagulant strategies for ACS: network meta-analysis of 42 randomised trials involving 117,353 patients
Key Points: Meta-analysis compares revascularization strategies in STEMI patients with multivessel disease Decrease in MACE with complete revascularization spurred by… Read more TCTMD: Meta-analysis Supports Benefit of Complete Revascularization in STEMI
GAITHERSBURG, MD — Over 2 days next week the US Food and Drug Administration (FDA) will hear from a panel… Read more heartwire NEWS: ‘Guarded Enthusiasm’ Builds for PCSK9 Inhibitors
More Preliminary Signs That The New Cholesterol Drugs May Improve Outcomes New drugs show promise for treating high cholesterol PCSK9 Inhibitors… Read more PCSK9 antibodies meta-analysis in media
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis Eliano Pio Navarese, Michalina Kołodziejczak,… Read more Annals of Internal Medicine: Mortality reduction with PCSK9 Antibodies
Available under Open Access Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised… Read more BMJ meta-analysis: optimal DAPT duration after PCI with DES